Tempus AI (NASDAQ:TEM) Stock Price Up 8.2%

Tempus AI, Inc. (NASDAQ:TEM - Get Free Report) shares were up 8.2% on Thursday . The stock traded as high as $50.95 and last traded at $50.28. Approximately 316,903 shares changed hands during trading, a decline of 74% from the average daily volume of 1,208,021 shares. The stock had previously closed at $46.49.

Analyst Ratings Changes

Several research analysts have weighed in on TEM shares. JPMorgan Chase & Co. upped their price objective on shares of Tempus AI from $42.00 to $47.00 and gave the stock an "overweight" rating in a report on Wednesday, August 7th. William Blair began coverage on Tempus AI in a research note on Tuesday, July 9th. They set an "outperform" rating on the stock. Bank of America initiated coverage on shares of Tempus AI in a report on Tuesday, July 9th. They set a "buy" rating and a $41.00 price objective on the stock. Stifel Nicolaus began coverage on shares of Tempus AI in a research report on Tuesday, July 9th. They set a "buy" rating and a $45.00 price target on the stock. Finally, Loop Capital started coverage on shares of Tempus AI in a report on Tuesday, July 9th. They set a "buy" rating and a $48.00 price target on the stock. One equities research analyst has rated the stock with a hold rating and nine have assigned a buy rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $45.56.

Tempus AI Trading Down 2.2 %

The firm's 50-day moving average is $46.41.

Tempus AI (NASDAQ:TEM - Get Free Report) last announced its quarterly earnings results on Tuesday, August 6th. The company reported ($6.77) earnings per share for the quarter, missing the consensus estimate of ($4.41) by ($2.36). The firm had revenue of $165.97 million during the quarter, compared to the consensus estimate of $159.10 million. On average, equities analysts anticipate that Tempus AI, Inc. will post -6.51 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Tempus AI

Several large investors have recently added to or reduced their stakes in TEM. Sandia Investment Management LP bought a new position in shares of Tempus AI in the 2nd quarter worth $136,000. Northwestern University purchased a new position in Tempus AI in the second quarter worth $491,000. Squarepoint Ops LLC bought a new position in Tempus AI in the second quarter valued at $633,000. WINTON GROUP Ltd purchased a new stake in Tempus AI during the second quarter valued at about $634,000. Finally, Scientech Research LLC purchased a new stake in Tempus AI during the second quarter valued at about $756,000.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.